Clinical Trial Update: A Preliminary Study About Unexplained Recurrent Miscarriage and Repeated Implantation Failure Patients Treated With Low-dose Lymphocyte Immunotherapy [Phase 1, Phase 2]

View source ↗

Summary

A preliminary Phase 1/2 clinical trial evaluated low-dose lymphocyte immunotherapy in women with unexplained recurrent miscarriage and recurrent implantation fa…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Implantation Failure
• Miscarriage

Drugs mentioned

• Low-dose lymphocyte immunotherapy

Snippet

Sponsor: Nanjing University | Conditions: Unexplained Recurrent Miscarriage and Recurrent Implantation Failure | Phase 1, Phase 2 | Status: COMPLETED